1. Home
  2. PRU vs ONC Comparison

PRU vs ONC Comparison

Compare PRU & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prudential Financial Inc.

PRU

Prudential Financial Inc.

HOLD

Current Price

$114.55

Market Cap

36.5B

Sector

Finance

ML Signal

HOLD

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$317.09

Market Cap

34.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRU
ONC
Founded
1875
2010
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.5B
34.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PRU
ONC
Price
$114.55
$317.09
Analyst Decision
Hold
Strong Buy
Analyst Count
11
12
Target Price
$116.80
$369.50
AVG Volume (30 Days)
1.7M
297.8K
Earning Date
02-03-2026
11-06-2025
Dividend Yield
4.67%
N/A
EPS Growth
N/A
N/A
EPS
7.27
0.58
Revenue
$57,598,000,000.00
$4,972,687,000.00
Revenue This Year
N/A
$895.40
Revenue Next Year
$1.62
$22.04
P/E Ratio
$15.89
$525.08
Revenue Growth
N/A
50.43
52 Week Low
$90.38
$170.99
52 Week High
$123.88
$385.22

Technical Indicators

Market Signals
Indicator
PRU
ONC
Relative Strength Index (RSI) 63.46 44.90
Support Level $107.22 $299.50
Resistance Level $118.31 $326.77
Average True Range (ATR) 1.98 9.54
MACD 0.16 -2.15
Stochastic Oscillator 66.06 42.41

Price Performance

Historical Comparison
PRU
ONC

About PRU Prudential Financial Inc.

Prudential Financial is one of the largest US life insurers, offering annuities, life insurance, and asset-management products. The United States and Japan are its two largest markets. Its US business contributed about 50% of adjusted 2024 earnings and includes institutional retirement (mostly pension risk transfer), individual retirement (annuities), group insurance, and individual life insurance. Its international business represented about 40% of adjusted earnings, with a strong market position in Japan, and the firm also has a presence in emerging markets like Brazil. The company's investment management business, PGIM, contributed approximately 10% of its 2024 adjusted earnings and has around $1.4 trillion in assets under management.

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

Share on Social Networks: